VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2019 | Bladder cancer treatment updates by Prof. Jones

Robert Jones, MD, PhD, of the University of Glasgow & Beatson West of Scotland Cancer Centre, Glasgow, UK, summarizes the key updates in the treatment options of urothelial cancer. Speaking at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, Prof. Jones talks about the emerging data on antibody-drug conjugates and also discusses the Phase II KEYNOTE-057 trial (NCT02625961) on the use of pembrolizumab in patients with high-risk non-muscle invasive bladder cancer (NMIBC).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter